The anti-tumoral activity of human glycoprotein HGP.92: A study with the mouse Lewis-lung-tumor cell

International Journal of Cancer

Volumn 70, Issue 4, 1997, Pages 416-422

  Fontan, Elisabeth ^a   Briend, Emmanuel ^a   Saklani Jusforgues, Hélène ^a   Fauve, Robert M ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; GLYCOPROTEIN HGP92; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; LEWIS CARCINOMA; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, LEWIS LUNG; CELL COMMUNICATION; DRUG CONTAMINATION; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MUCOPROTEINS; NITRIC OXIDE; REACTIVE OXYGEN SPECIES; TIME FACTORS;

EID: 0031018541     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970207)70:4<416::AID-IJC8>3.0.CO;2-Z     Document Type: Article

References (29)

1. BRIEND, E., COLLE, J-H., FONTAN, E., SAKLANI-JUSFORGUES, H. and FAUVE, R.M., Human glycoprotein HGP.92 induces cytokine synthesis in mouse mononuclear phagocytes. Int. Immunol., 7, 1753-1761 (1995).
2. BROWN, K.M., MUCHMORE, A.V. and ROSENSTREICH, D.L., Uromodulin, an immunosuppressive protein derived from pregnancy urine, is an inhibitor of interleukin 1. Proc. nat. Acad. Sci. (Wash.), 83, 91119-9123 (1986).
3. BRUNDA, M.J., LUISTRO, L., WARRIER, R.R., WRIGHT, R.B., HUBBARD, B.R., MURPHY, M., WOLF, S.F. and GATELY, M.K., Anti-tumor and anti-metastatic activity of interleukin-12 against murine tumors. J. exp. Med., 178, 1223-1227 (1993).
4. 2. Proc. nat. Acad. Sci. (Wash.), 85, 8037-8041 (1988).
5. DING, A.H., NATHAN, C.F. and STHUER, D.J., Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol, 141, 2407-2411 (1988).
6. FAUVE, R.M., JUSFORGUES, H. and HEVIN, M.B., Maintenance of granuloma macrophases in serum-free medium. J. Immunol. Methods., 64, 345-351 (1983).
7. FONTAN, E., BRIEND, E., SAKLANI-JUSFORGUES, H., D'ALAYER, J., VANDEKERCKOVE, J. and FAUVE, R.M., A 92-kDa human immunostimulatory protein. Proc. nat. Acad. Sci. (Wash.), 91, 8353-8357 (1994).
8. FONTAN, E. and FAUVE, R.M., Inflammation and anti-tumor resistance. IV. Induction of cytostatic activity of murine peritoneal cells by a mouse granuloma protein. Int. J. Cancer, 42, 267-272 (1988).
9. FONTAN, E., SAKLANI, H. and FAUVE, R.M. Macrophage-induced cytotoxicity and anti-metastatic activity of a 43-kDa human urinary protein against the Lewis tumor. Int. J. Cancer, 53, 131-136 (1993).
10. HESSION, C. and 13 OTHERS, Uromodulin (Tamm-Horsfall glycoprotein) a renal ligand for lymphokines. Science. 237, 1479-1484 (1987).
11. HIBBS, J.B., TAINTOR, R.R., VAVRIN, Z. and RACHLIN, E.M., Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. biophys. Res. Comm., 157, 87-94 (1988).
12. HIBBS, J.B., VAVRIN, Z. and TAINTOR, R.R., L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immunol., 138, 550-554 (1987).
13. HORTON, J.K., DAVIES, M., TOPLEY, N., THOMAS, D. and WILLIAMS, J.D., Activation of the inflammatory response of neutrophils by Tamm-Horsfall glycoprotein. Kidney Int., 37, 717-726 (1990).
14. HUNT, J.S. and McGIVEN, A.R., Stimulation of human peripheral-blood lymphocytes by Tamm-Horsfall urinary glycoprotein. Immunology 35, 391-396 (1978).
15. JAIN, R.K., Physiological barriers to delivery monoclonal antibodies and other molecules in tumors. Cancer Res. (suppl.), 50, 814s-819s (1990).
16. KUMAR, S., JASANI, B., HUNT, J.S., MOFFAT, D.B. and ASSCHER, A.W., A system for accurate immunolocalization of Tamm-Horsfall protein in renal biopsies. Histochem. J., 17, 1251-1256 (1985).
17. LORSBACH, R.B., MURPHY, W.J., LOWENSTEIN, C.J., SNYDER, S.H. and RUSSEL, S.W., Expression of the nitric-oxide-synmase gene in mouse macrophage activated for tumor-cell killing: molecular basis for the synerey between interferon-γ and lipopolysaccharide. J. biol. Chem., 268, 1908-1912 (1993).
18. NATHAN, C.F., SILVERSTEIN, S.C., BRUKNER, L.H. and COHN, Z.A., Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacoloaic triggering of effector cells and the release of hydrogen peroxide. J. exp. Med., 149, 84-88 (1979a).
19. NATHAN, C.F., SILVERSTEIN, S.C., BRUKNER, L.H. and COHN, Z.A., Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as mediator of cytotoxicity. J. exp. Med., 149, 100-113 (1979b).
20. ODA, S., SATO, M., TOYOSHIMA, S. and OSAWA, T., Binding of activated macrophages to tumor cells through a macrophage lectin and its role in macrophage tumoricidal activity. J. Biochem., 105, 1040-1043 (1989).
21. PORGADOR, A., TZEHOVAL, E., KATZ, A., VADA, E., REVEL, M., FELDMAN, M. and EISENBACH, L., lnterleukin-6 gene transfection into Lewis lungcarcinoma tumour cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells. Cancer Res., 52, 3679-3686 (1992).
22. SIKRI, K.L., FOSTER, C.L., MACHUGH, N. and MARSHALL, R.D., Localisation of Tamm-Horsfall glycoprotein in the kidney using immunogluorescence and immunoelectron microscopical techniques. J. Anat., 132, 597-601 (1981).
23. STUEHR, D.J. and MARLETTA, M.A., Synthesis of nitrite and nitrate in murine macrophage cell lines. Cancer Res., 47, 5590-5594 (1987).
24. STUEHR, D.J. and NATHAN, C.F., Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. exp. Med., 169, 1543-1547 (1989).
25. URBAN, J.L., SHEPARD, H.M., ROTHSTEIN, J.L., SUGARMAN, B.J. and SCHREIBER, H., Tumor necrosis factor: a potent effector molecule for tumor-cell killing by activated macrophages. Proc. nat. Acad. Sci. (Wash.), 83, 5233-5237 (1986).
26. WEISS, S.J., LOBUGLIO, A.F. and KESSLER, H.B., Oxidative mechanism of monocyte-mediated cytotoxicity. Proc. nat. Acad. Sci. (Wash.), 77, 584-588 (1980).
27. WHITWORTH, P.W., PAK, C., ESGRO, J., KLEINERMAN, E. and FIDLER, I., Macrophages and cancer. Cancer Metast. Rev., 8, 319-351 (1990).
28. YU, C.L., LIN, W.M., LIAO, T.S., TSAI, C.Y., SUN, K.H. and CHEN, K-H., Tamm-Horsfall glycoprotein (THG) purified from normal human pregnancy urine increases phagocytosis, complement-receptor expression and arachidonic-acid metabolism of polymorphonuclear neutrophils. Immunopharmacology, 24, 181-190 (1992).
29. YU, C.L., TSAI, C-Y., LIN, W.M., LIAO, T.S., CHEN, H-L., SUN, K.H. and CHEN, K-H., Tamm-Horsfall urinary glycoprotein enhances monokine release and augments lymphocyte proliferation. Immunopharmacology, 26, 249-258 (1993).